• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Proteomic Ligandability Maps of Spirocycle Acrylamide Stereoprobes Identify Covalent ERCC3 Degraders.螺环丙烯酰胺立体探针的蛋白质组配体图谱鉴定共价 ERCC3 降解剂。
J Am Chem Soc. 2024 Apr 17;146(15):10393-10406. doi: 10.1021/jacs.3c13448. Epub 2024 Apr 3.
2
Multi-tiered chemical proteomic maps of tryptoline acrylamide-protein interactions in cancer cells.多层次化学蛋白质组学图谱揭示了色胺丙烯酰胺与癌细胞中蛋白质的相互作用。
Nat Chem. 2024 Oct;16(10):1592-1604. doi: 10.1038/s41557-024-01601-1. Epub 2024 Aug 13.
3
Proteomic Ligandability Maps of Phosphorus(V) Stereoprobes Identify Covalent TLCD1 Inhibitors.磷(V)立体探针的蛋白质组配体可及性图谱鉴定出共价TLCD1抑制剂。
J Am Chem Soc. 2025 May 7;147(18):15554-15566. doi: 10.1021/jacs.5c01944. Epub 2025 Apr 23.
4
Proteomic Ligandability Maps of Phosphorus(V) Stereoprobes Identify Covalent TLCD1 Inhibitors.磷(V)立体探针的蛋白质组配体可及性图谱鉴定出共价TLCD1抑制剂。
bioRxiv. 2025 Jan 31:2025.01.31.635883. doi: 10.1101/2025.01.31.635883.
5
Expanding the ligandable proteome by paralog hopping with covalent probes.通过共价探针的旁系同源跳跃扩展可配体蛋白质组。
bioRxiv. 2024 Jan 19:2024.01.18.576274. doi: 10.1101/2024.01.18.576274.
6
Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3-MYC Interactions as a Target in Pancreatic Cancer.对条件重编程的患者源性癌细胞进行筛选,确定ERCC3-MYC相互作用为胰腺癌的一个靶点。
Clin Cancer Res. 2016 Dec 15;22(24):6153-6163. doi: 10.1158/1078-0432.CCR-16-0149. Epub 2016 Jul 6.
7
XPB, a subunit of TFIIH, is a target of the natural product triptolide.XPB 是 TFIIH 的一个亚基,是天然产物雷公藤红素的作用靶点。
Nat Chem Biol. 2011 Mar;7(3):182-8. doi: 10.1038/nchembio.522. Epub 2011 Jan 30.
8
An allosteric cyclin E-CDK2 site mapped by paralog hopping with covalent probes.通过与共价探针进行旁系同源物跳跃映射的变构细胞周期蛋白E-CDK2位点。
Nat Chem Biol. 2025 Mar;21(3):420-431. doi: 10.1038/s41589-024-01738-7. Epub 2024 Sep 18.
9
Targeted Protein Degradation by Electrophilic PROTACs that Stereoselectively and Site-Specifically Engage DCAF1.通过立体选择性和位点特异性结合 DCAF1 的亲电 PROTAC 实现靶向蛋白降解。
J Am Chem Soc. 2022 Oct 12;144(40):18688-18699. doi: 10.1021/jacs.2c08964. Epub 2022 Sep 28.
10
Chemical Proteomic Discovery of Isotype-Selective Covalent Inhibitors of the RNA Methyltransferase NSUN2.化学蛋白质组学发现 RNA 甲基转移酶 NSUN2 的同型选择性共价抑制剂。
Angew Chem Int Ed Engl. 2023 Dec 18;62(51):e202311924. doi: 10.1002/anie.202311924. Epub 2023 Nov 14.

引用本文的文献

1
COOKIE-Pro: Covalent Inhibitor Binding Kinetics Profiling on the Proteome Scale.COOKIE-Pro:蛋白质组规模上的共价抑制剂结合动力学分析
bioRxiv. 2025 Jun 22:2025.06.19.660637. doi: 10.1101/2025.06.19.660637.
2
Complexoform-restricted covalent TRMT112 ligands that allosterically agonize METTL5.对TRMT112具有变构激动作用的复合形式受限共价TRMT112配体。
bioRxiv. 2025 May 25:2025.05.25.655995. doi: 10.1101/2025.05.25.655995.
3
Advancing Covalent Ligand and Drug Discovery beyond Cysteine.超越半胱氨酸推进共价配体与药物发现
Chem Rev. 2025 Jul 23;125(14):6653-6684. doi: 10.1021/acs.chemrev.5c00001. Epub 2025 May 22.
4
A Guide to Extrachromosomal DNA: Cancer's Dynamic Circular Genome.《染色体外DNA指南:癌症的动态环状基因组》
Cancer Discov. 2025 Jun 3;15(6):1105-1114. doi: 10.1158/2159-8290.CD-25-0230.
5
Nucleotide Excision Repair: Insights into Canonical and Emerging Functions of the Transcription/DNA Repair Factor TFIIH.核苷酸切除修复:对转录/DNA修复因子TFIIH的经典及新功能的见解
Genes (Basel). 2025 Feb 19;16(2):231. doi: 10.3390/genes16020231.
6
Identification of a novel allosteric binding site on the catalytic domain of NF-κB inducing kinase (NIK).在NF-κB诱导激酶(NIK)催化结构域上鉴定出一个新的变构结合位点。
RSC Med Chem. 2025 Feb 7. doi: 10.1039/d4md00963k.
7
Proteomic Ligandability Maps of Phosphorus(V) Stereoprobes Identify Covalent TLCD1 Inhibitors.磷(V)立体探针的蛋白质组配体可及性图谱鉴定出共价TLCD1抑制剂。
bioRxiv. 2025 Jan 31:2025.01.31.635883. doi: 10.1101/2025.01.31.635883.
8
Covalent Proximity Inducers.共价接近诱导剂
Chem Rev. 2025 Jan 8;125(1):326-368. doi: 10.1021/acs.chemrev.4c00570. Epub 2024 Dec 18.
9
Coordinated inheritance of extrachromosomal DNAs in cancer cells.癌细胞中外源 DNA 的协同遗传。
Nature. 2024 Nov;635(8037):201-209. doi: 10.1038/s41586-024-07861-8. Epub 2024 Nov 6.
10
Redirecting the pioneering function of FOXA1 with covalent small molecules.用共价小分子重定向 FOXA1 的启动功能。
Mol Cell. 2024 Nov 7;84(21):4125-4141.e10. doi: 10.1016/j.molcel.2024.09.024. Epub 2024 Oct 15.

本文引用的文献

1
Assigning functionality to cysteines by base editing of cancer dependency genes.通过碱基编辑癌症相关基因来赋予半胱氨酸功能。
Nat Chem Biol. 2023 Nov;19(11):1320-1330. doi: 10.1038/s41589-023-01428-w. Epub 2023 Oct 2.
2
Direct mapping of ligandable tyrosines and lysines in cells with chiral sulfonyl fluoride probes.手性磺酰氟探针在细胞中对可配体化的酪氨酸和赖氨酸的直接作图。
Nat Chem. 2023 Nov;15(11):1616-1625. doi: 10.1038/s41557-023-01281-3. Epub 2023 Jul 17.
3
Proteomic discovery of chemical probes that perturb protein complexes in human cells.蛋白质组学发现化学探针,可扰乱人细胞中的蛋白质复合物。
Mol Cell. 2023 May 18;83(10):1725-1742.e12. doi: 10.1016/j.molcel.2023.03.026. Epub 2023 Apr 20.
4
Remodeling oncogenic transcriptomes by small molecules targeting NONO.通过靶向 NONO 的小分子重塑致癌转录组。
Nat Chem Biol. 2023 Jul;19(7):825-836. doi: 10.1038/s41589-023-01270-0. Epub 2023 Mar 2.
5
Targeted Protein Degradation by Electrophilic PROTACs that Stereoselectively and Site-Specifically Engage DCAF1.通过立体选择性和位点特异性结合 DCAF1 的亲电 PROTAC 实现靶向蛋白降解。
J Am Chem Soc. 2022 Oct 12;144(40):18688-18699. doi: 10.1021/jacs.2c08964. Epub 2022 Sep 28.
6
Selective inhibitors of JAK1 targeting an isoform-restricted allosteric cysteine.针对同种型受限变构半胱氨酸的 JAK1 选择性抑制剂。
Nat Chem Biol. 2022 Dec;18(12):1388-1398. doi: 10.1038/s41589-022-01098-0. Epub 2022 Sep 12.
7
Selective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domain.靶向自调节 ARM 结构域中变构半胱氨酸的 SARM1 选择性抑制剂。
Proc Natl Acad Sci U S A. 2022 Aug 30;119(35):e2208457119. doi: 10.1073/pnas.2208457119. Epub 2022 Aug 22.
8
Pharmacology of Antagonism of GPCR.GPCR 拮抗作用的药理学
Biol Pharm Bull. 2022;45(6):669-674. doi: 10.1248/bpb.b22-00143.
9
A Preclinical Study to Repurpose Spironolactone for Enhancing Chemotherapy Response in Bladder Cancer.一项将螺内酯重新用于增强膀胱癌化疗反应的临床前研究。
Mol Cancer Ther. 2022 May 4;21(5):786-798. doi: 10.1158/1535-7163.MCT-21-0613.
10
The NEK family of serine/threonine kinases as a biomarker for cancer.丝氨酸/苏氨酸激酶的NEK家族作为癌症的生物标志物。
Clin Exp Med. 2023 Feb;23(1):17-30. doi: 10.1007/s10238-021-00782-0. Epub 2022 Jan 17.

螺环丙烯酰胺立体探针的蛋白质组配体图谱鉴定共价 ERCC3 降解剂。

Proteomic Ligandability Maps of Spirocycle Acrylamide Stereoprobes Identify Covalent ERCC3 Degraders.

机构信息

Department of Chemistry, Scripps Research, La Jolla, California 92037, United States.

Vividion Therapeutics, San Diego, California 92121, United States.

出版信息

J Am Chem Soc. 2024 Apr 17;146(15):10393-10406. doi: 10.1021/jacs.3c13448. Epub 2024 Apr 3.

DOI:10.1021/jacs.3c13448
PMID:38569115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11211653/
Abstract

Covalent chemistry coupled with activity-based protein profiling (ABPP) offers a versatile way to discover ligands for proteins in native biological systems. Here, we describe a set of stereo- and regiochemically defined spirocycle acrylamides and the analysis of these electrophilic "stereoprobes" in human cancer cells by cysteine-directed ABPP. Despite showing attenuated reactivity compared to structurally related azetidine acrylamide stereoprobes, the spirocycle acrylamides preferentially liganded specific cysteines on diverse protein classes. One compound termed ZL-12A promoted the degradation of the TFIIH helicase ERCC3. Interestingly, ZL-12A reacts with the same cysteine (C342) in ERCC3 as the natural product triptolide, which did not lead to ERCC3 degradation but instead causes collateral loss of RNA polymerases. ZL-12A and triptolide cross-antagonized one another's protein degradation profiles. Finally, we provide evidence that the antihypertension drug spironolactone─previously found to promote ERCC3 degradation through an enigmatic mechanism─also reacts with ERCC3_C342. Our findings thus describe monofunctional degraders of ERCC3 and highlight how covalent ligands targeting the same cysteine can produce strikingly different functional outcomes.

摘要

共价化学结合基于活性的蛋白质谱分析(ABPP)为在天然生物系统中发现蛋白质配体提供了一种通用的方法。在这里,我们描述了一组立体和区域化学定义的螺环丙烯酰胺,并通过半胱氨酸定向 ABPP 分析了这些亲电“立体探针”在人类癌细胞中的作用。尽管与结构相关的氮杂环丁烷丙烯酰胺立体探针相比,反应性减弱,但螺环丙烯酰胺优先与不同蛋白质类别的特定半胱氨酸结合。一种称为 ZL-12A 的化合物促进了 TFIIH 解旋酶 ERCC3 的降解。有趣的是,ZL-12A 与 ERCC3 中的天然产物雷公藤内酯反应的半胱氨酸(C342)相同,雷公藤内酯不会导致 ERCC3 降解,而是导致 RNA 聚合酶的附带损失。ZL-12A 和雷公藤内酯相互拮抗彼此的蛋白质降解谱。最后,我们提供的证据表明,降压药螺内酯——以前通过一种神秘的机制被发现促进 ERCC3 降解——也与 ERCC3_C342 反应。我们的发现因此描述了 ERCC3 的单功能降解剂,并强调了靶向相同半胱氨酸的共价配体如何产生截然不同的功能结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ee/11211653/8f6580a6e477/nihms-2002900-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ee/11211653/76dc9ead4c3c/nihms-2002900-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ee/11211653/7ec21604fd20/nihms-2002900-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ee/11211653/6b4037a85d67/nihms-2002900-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ee/11211653/4a3f9dfbf912/nihms-2002900-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ee/11211653/0a1803a7c0d6/nihms-2002900-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ee/11211653/8f6580a6e477/nihms-2002900-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ee/11211653/76dc9ead4c3c/nihms-2002900-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ee/11211653/7ec21604fd20/nihms-2002900-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ee/11211653/6b4037a85d67/nihms-2002900-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ee/11211653/4a3f9dfbf912/nihms-2002900-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ee/11211653/0a1803a7c0d6/nihms-2002900-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ee/11211653/8f6580a6e477/nihms-2002900-f0006.jpg